What is Catalyst Pharmaceutical's intangible purchases?

Catalyst Pharmaceutical (CPRX) reported intangible purchases of $0 in Q3 2024.

What does intangible purchases mean?

Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.

Catalyst Pharmaceutical CPRX Intangible Purchases

Intangible Purchases at other companies

PTC TherapeuticsPTCT

$156K-80.7%

Acadia PharmaceuticalsACAD

$0-100%

Amneal Pharmaceuticals, Inc.AMRX

$7.85M+86.9%

Mirum Pharmaceuticals, Inc.MIRM

$10M—

BridgeBio PharmaBBIO

$0-100%

BiogenBIIB

$0-100%

Other financials

Income statement

See full

Revenue$149.4M+5.6%

Gross profit$134.9M+9.2%

Operating income$73.2M+15.6%

Net income$63.7M+12.3%

EPS (diluted)$0.50+11.1%

Balance sheet

See full

Cash & equivalents$755.9M+30.2%

Total debt$2.7M-13.3%

Total equity$1.0B+27.5%

Total assets$1.1B+26.3%

Cash flow

See full

Operating cash flow$59.6M-0.8%

CapEx$27.0K—

Free cash flow$59.6M-0.8%

Valuation

See full

Market cap$3.84B+2.7%

Enterprise value$3.09B-4.1%

P/E17.4×-1.6×

P/S6.4×-0.6×

Profitability

See full

Gross margin86%-0.2pp

Operating margin44.8%+1.6pp

Net margin37.1%+0.2pp

FCF margin34.9%-15.2pp

Returns & leverage

See full

Return on equity24.5%-4.6pp

Debt / equity0×0.0×

Current ratio7.1×+1.0×

Where this comes from

Reported directly by Catalyst Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Catalyst Pharmaceutical’s 10-Q, filed November 6, 2024, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Catalyst Pharmaceutical's intangible purchases?: Catalyst Pharmaceutical (CPRX) reported intangible purchases of $0 in Q3 2024.
What does intangible purchases mean?: Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.